kidney disease

Amgen Benefits From Affymax Recall

Amgen Benefits From Affymax Recall

Seeking Alpha

Zerenex Kidney Treatment: A Game Changer for Keryx Biopharmaceuticals

Zerenex Kidney Treatment: A Game Changer for Keryx Biopharmaceuticals

Motley Fool

A Closer Look At Keryx Biopharmaceuticals' Phase III Result Announcement

A Closer Look At Keryx Biopharmaceuticals' Phase III Result Announcement

Seeking Alpha

Keryx shares more than doubles on kidney drug data

Keryx shares more than doubles on kidney drug data

Yahoo/AP

Keryx shares soar on kidney drug results

Keryx shares soar on kidney drug results

Yahoo/AP

Will Kidney Disease Drug Success Push This Stock Higher?

Will Kidney Disease Drug Success Push This Stock Higher?

Motley Fool

Is Keryx Spring Loaded on Zerenex?

Is Keryx Spring Loaded on Zerenex?

Motley Fool

Otsuka's Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clinical Trial

Otsuka's Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clinical Trial

Business Wire

Abbott, Reata kidney disease drug trial stopped

Abbott, Reata kidney disease drug trial stopped

Reuters

A Fresh Look At KERX; High Odds For Zerenex Phase III Success

A Fresh Look At KERX; High Odds For Zerenex Phase III Success

Yahoo/Reuters